Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures?
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 13 (2) , 165-172
- https://doi.org/10.1016/s1053-0770(99)90081-2
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Pulmonary Effects of Methylprednisolone in Patients Undergoing Coronary Artery Bypass Grafting and Early Tracheal ExtubationAnesthesia & Analgesia, 1998
- Aprotinin but Not Tranexamic Acid Inhibits Cytokine-Induced Inducible Nitric Oxide Synthase ExpressionAnesthesia & Analgesia, 1997
- Differing Effects of Aprotinin and ϵ-Aminocaproic Acid on Cytokine-Induced Inducible Nitric Oxide Synthase ExpressionThe Annals of Thoracic Surgery, 1997
- “Low-Dose” Aprotinin Modifies Hemostasis but Not Proinflammatory Cytokine ReleaseThe Annals of Thoracic Surgery, 1997
- Heparin-coated circuits and aprotinin prime for coronary artery bypass graftingThe Annals of Thoracic Surgery, 1996
- Aprotinin® diminishes inflammatory processesInternational Journal of Cardiology, 1996
- Cytokine Induction During Cardiac Surgery: Analysis of TNF-? Expression Pre-and Postcardiopulmonary BypassJournal of Cardiac Surgery, 1995
- Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokinesCardiovascular Research, 1995
- RETRACTED: Circulating adhesion molecules in cardiac operations: Influence of high-dose aprotininThe Annals of Thoracic Surgery, 1995
- Receptor‐Based Pharmacokinetic‐Pharmacodynamic Analysis of CorticosteroidsThe Journal of Clinical Pharmacology, 1993